title: Treatment of delayed-type hypersensitivity with inhibitors of the VLA-4 integrin.
authors.affiliation: CYTEL Corporation, San Diego, CA 92121, USA.
authors.forename: S
authors.initials: S
authors.lastname: Tamraz
authors.forename: T
authors.initials: T
authors.lastname: Arrhenius
authors.forename: A
authors.initials: A
authors.lastname: Chiem
authors.forename: M J
authors.initials: MJ
authors.lastname: Forrest
authors.forename: F C
authors.initials: FC
authors.lastname: Gaeta
authors.forename: Y B
authors.initials: YB
authors.lastname: He
authors.forename: J
authors.initials: J
authors.lastname: Lei
authors.forename: A
authors.initials: A
authors.lastname: Maewal
authors.forename: M L
authors.initials: ML
authors.lastname: Phillips
authors.forename: L W
authors.initials: LW
authors.lastname: Vollger
mesh_terms: D000818:Animals; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000628:therapy*; D039041:Integrin alpha4beta1; D016023:Integrins / Q000037:antagonists & inhibitors*; D051379:Mice; D016201:Receptors, Lymphocyte Homing / Q000037:antagonists & inhibitors*
chemical_list: D039041:Integrin alpha4beta1; D016023:Integrins; D016201:Receptors, Lymphocyte Homing